MCV and Merkel cell carcinoma: a molecular success story.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesMerkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment optionsThe conundrum of causality in tumor virology: the cases of KSHV and MCVDistinct genetic alterations in small cell carcinoma from different anatomic sitesHow Polyomaviruses Exploit the ERAD Machinery to Cause InfectionEpigenetic impact of infection on carcinogenesis: mechanisms and applicationsViruses and human cancers: a long road of discovery of molecular paradigms.The consequences for human health of stratospheric ozone depletion in association with other environmental factors.Pathogen-driven cancers and emerging immune therapeutic strategies.Seroprevalence of Merkel cell polyomavirus in the general rural population of Anyang, China.Merkel cell carcinoma dependence on bcl-2 family members for survival.Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCFFbw7.The raccoon polyomavirus genome and tumor antigen transcription are stable and abundant in neuroglial tumorsRemoval of a small C-terminal region of JCV and SV40 large T antigens has differential effects on transformationThe rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology.Transformation with oncogenic Ras and the simian virus 40 T antigens induces caspase-dependent sensitivity to fatty acid biosynthetic inhibitionSystemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stageReversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinomaThe landscape of viral expression and host gene fusion and adaptation in human cancerMerkel cell carcinoma: the past, the present, and the futureHuman Merkel cell polyomavirus: virological background and clinical implications.High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens.Merkel cell carcinoma: Do you know your guidelines?Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma.Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population.Entry, infection, replication, and egress of human polyomaviruses: an update.Clinicopathological characteristics of head and neck Merkel cell carcinomas.Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment.Spontaneous lung metastasis formation of human Merkel cell carcinoma cell lines transplanted into scid mice.Unexpected histopathologic result of a wide surgical excision of a bleeding lesion of the skin: a case of Merkel cell carcinoma of the leg.Characterization of functional domains in the Merkel cell polyoma virus Large T antigen.The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expression.Origins of cancer symposium report: beyond the tumor cell.Infection and coinfection by human papillomavirus, Epstein-Barr virus and Merkel cell polyomavirus in patients with squamous cell carcinoma of the larynx: a retrospective study
P2860
Q21285083-965D03C9-E593-47BC-9D50-7C4097492C9FQ26796421-D2939AD5-3CFE-493F-84DD-C4338F57CD98Q26863112-412AB495-EBE9-4538-A23D-EB688482A811Q27008242-3F498E48-C7B4-450B-9D4C-9D039CEEA1E3Q27468807-F73BAB76-3477-4355-8A54-13617BB21F57Q28066519-8F32FE9C-337A-4EA8-82DF-D93448B691C7Q30384388-D0695F8B-68C5-43F9-85CD-7D201168AD2CQ30868560-4963C7E1-4A23-4CF3-ACD4-403AFB0FC0A3Q34054175-4F30F0AA-92E8-4628-BA82-F2BDCE05784BQ34128714-ACB9DEDE-EB97-4FCB-8F2F-5E746A8944C3Q34273863-922A8B5D-6874-4FD1-BC06-B2329E1D3D61Q34364753-5CDA3CF4-DAFB-4D95-B4B6-11376DC06386Q34593626-68E2FB0A-9FE9-40AA-A525-3AE83315C482Q34620506-C46B8A17-FE26-4C13-9845-F03D40FB5732Q34629128-B168045F-521E-43D3-A48C-AD29B6DE8527Q35760413-6671F25B-356F-40E7-AAD1-3F40C35B469BQ36605019-3CD4FB7E-FE3B-4D88-8070-99334234BB7AQ36605917-0046EAD5-2E0E-43D9-9C1E-9E252A1D341BQ37250972-73B95783-BD2E-46F9-BAF9-0EBDD5C5BB23Q38108313-A0D94355-B36E-4AA4-B23C-E62342E2E3EFQ38115562-DE3789E9-F182-4E9F-A55E-70E5FAD47D9AQ38326994-1E719224-056F-424D-B83D-77102394DC05Q38682926-B24C6AFE-1734-44F4-BD7A-BEE09B2F7EB4Q38738614-207811DF-A771-4848-9D21-58E7024BA1DDQ39064776-D1AD54C9-4FA1-4C7B-983B-5A3D7DAD634AQ39126203-48D13D25-1FB0-4990-8B39-689B81B00567Q39571471-1C9893CE-93AC-4E52-A1FD-9EF546113976Q40100093-8808B395-8C6E-403D-A041-24102123C9C4Q40256395-13F8258D-5B23-403B-BE0C-AF6BCAFFDB20Q40853758-9B0EB9C7-F150-4EB8-B8C9-40AE71E22741Q41744694-144ABF48-7FFE-4451-904F-55D389570EF2Q42266941-18F4A70A-FDEA-4D7A-AC0D-0B87335DAB53Q55412159-50C23A4F-E584-442E-8808-4AF0522E4127Q58569093-7B94A60B-48A7-4954-A1DA-7317869860B5
P2860
MCV and Merkel cell carcinoma: a molecular success story.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MCV and Merkel cell carcinoma: a molecular success story.
@en
type
label
MCV and Merkel cell carcinoma: a molecular success story.
@en
prefLabel
MCV and Merkel cell carcinoma: a molecular success story.
@en
P2860
P50
P1476
MCV and Merkel cell carcinoma: a molecular success story.
@en
P2860
P304
P356
10.1016/J.COVIRO.2012.05.007
P577
2012-06-17T00:00:00Z